41 – 50 of 147
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
N-terminal prosomatostatin as a risk marker for cardiovascular disease and diabetes in a general population
(
- Contribution to journal › Article
-
Mark
The genetic architecture of type 2 diabetes
(
- Contribution to journal › Article
- 2015
-
Mark
Cystatin C Is Not Causally Related to Coronary Artery Disease.
(
- Contribution to journal › Article
-
Mark
Analysis of Low Frequency Protein Truncating Stop-Codon Variants and Fasting Concentration of Growth Hormone.
(
- Contribution to journal › Article
-
Mark
Intakes of omega-3 polyunsaturated fatty acids and blood pressure change over time: Possible interaction with genes involved in 20-HETE and EETs metabolism.
(
- Contribution to journal › Article
-
Mark
Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk.
(
- Contribution to journal › Article
-
Mark
Duffy antigen receptor genetic variant and the association with Interleukin 8 levels.
(
- Contribution to journal › Article
-
Mark
The growth hormone receptor exon 3 deleted/full-length polymorphism is associated with central adiposity in the general population.
(
- Contribution to journal › Article
-
Mark
Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci.
(
- Contribution to journal › Article
-
Mark
GWAS-identified loci for coronary heart disease are associated with intima-media thickness and plaque presence at the carotid artery bulb.
(
- Contribution to journal › Article